Brands
Planet 13 Schedules Release of Q4 2024 Financial Results
LOS ANGELES- Planet 13 Holdings Inc. a vertically integrated multi-state cannabis company, has announced that it will release its financial results for the fourth quarter and full year ending December 31, 2024, on March 26, 2025, after market close. Following the release, Planet 13's executive team, including Co-CEOs Bob Groesbeck and Larry Scheffler, along ...
MindMed Appoints Matt Wiley as Chief Commercial Officer
LOS ANGELES-Mind Medicine (MindMed) Inc. a biopharmaceutical company specializing in brain health disorders, has announced the appointment of Matt Wiley as Chief Commercial Officer (CCO). In his new role, Mr. Wiley will oversee MindMed's commercial strategy, particularly in preparation for the potential launch of MM120, an orally disintegrating tablet targeting generalized anxiety disorder (GAD) ...
Glass House Brands Schedules Conference Call to Discuss 2024 Financial Results
LOS ANGELES- Glass House Brands Inc., a vertically integrated cannabis company, has announced plans to release its financial results for the fourth quarter and full year ending December 31, 2024. The company will host a conference call on March 25, 2025, at 5:00 p.m. Eastern Time to discuss these results. Participation Details: Webcast Access: ...
TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results
LOS ANGELES- TerrAscend Corp., a cannabis company, has announced its financial results for the fourth quarter and full year ending December 31, 2024. Fourth Quarter 2024 Highlights Net Revenue: $74.4 million, a 0.3% increase from $74.2 million in the third quarter of 2024. Gross Profit Margin: 50.2%, up from 48.8% in the previous quarter. GAAP ...
Former NBA Player Iman Shumpert Introduces ‘TSA APPROVED’ Cannabis Brand in New York
LOS ANGELES- Former NBA player Iman Shumpert has launched a cannabis brand, TSA APPROVED, in partnership with Glenmere Farms, a licensed cannabis producer in New York. The brand aims to offer high-quality cannabis products while contributing to the state’s regulated market. Shumpert’s entry into the cannabis industry follows a broader shift in professional sports, including ...
Glass House Brands Secures $50 Million Senior Secured Loan
LOS ANGELES- Glass House Brands Inc., a vertically integrated cannabis company, has secured a new $50 million senior secured loan maturing on January 31, 2030. This facility replaces the previous loan set to mature in November 2026, extending the final balloon payment by an additional three years. The loan carries a fixed interest rate of ...
LEEF Brands to Enter New York’s Expanding Cannabis Market with Acquisition of Tier 1 Processing License
LOS ANGELES- LEEF Brands Inc. California-based cannabis extraction company, has announced the signing of a binding Letter of Intent to acquire a Tier 1 processing license in New York. This strategic move positions LEEF to enter New York's rapidly growing cannabis market, which is projected to reach $1.5 billion in sales by 2025. In addition ...
Awakn Life Sciences Secures $535,000 Credit Facility to Advance Addiction Treatment Programs
LOS ANGELES - Awakn Life Sciences Corp. a clinical-stage biotechnology company focusing on treatments for substance use and mental health disorders, has secured an unsecured credit facility of up to US$535,000 from an arm's length creditor. This facility allows the company to draw funds in multiple advances, with the principal due on December 5, 2026, ...
Regulatory Challenges for Hemp Beverages in the USA
LOS ANGELES - The hemp beverage industry in the United States is growing rapidly, driven by consumer demand for wellness-focused and sustainable alternatives to traditional drinks. According to Fortune Business Insights, the U.S. cannabis beverage market is projected to reach $81.44 billion by 2032, supported by the legalization of cannabis products in several states. Despite ...
The Rise of Cannabis Beverages: Trends and Market Insights for 2025
LOS ANGELES - Cannabis beverages are gaining traction in the health and wellness industry as a new way to deliver cannabinoid benefits. As 2025 approaches, this market is projected to grow significantly, evolving consumer preferences and advancements in formulation technologies, coupled with global cannabis legalization. This analysis delves into the key factors fueling the rise ...
Willow Biosciences Reports Q3 2024
LOS ANGELES- Willow Biosciences Inc., a biotechnology firm specializing in the industrial production of functional ingredients, has reported its financial results for the third quarter of 2024. The company achieved record revenue of $1.7 million during this period, marking a significant increase from the $674,000 reported in the same quarter of 2023. Despite this revenue ...
Medicinal Cannabis Companies Target Veterans with Social Media Promotions, Raising Ethical Concerns
LOS ANGELES- Recent reports indicate that medicinal cannabis companies are increasingly targeting veterans through social media platforms, promoting free products and subscription services. This marketing strategy aims to attract veterans by offering complimentary samples and ongoing product deliveries, leveraging social media's extensive reach to engage this demographic. Advocates argue that such promotions provide veterans with ...
Urbana Breathes New Life into Historic Luka’s Taproom with a New Cannabis Dispensary and Lounge in Oakland
Honoring a Beloved Oakland Landmark, Urbana Introduces a New Paradigm in Cannabis Retail and Consumption OAKLAND, CA – Urbana, one of Northern California’s premier cannabis brands, is thrilled to announce the opening of its newest dispensary and consumption lounge in the heart of Oakland. Located in the historic Luka’s Taproom, Urbana’s newest site pays tribute ...
BudLabs: The App Innovating How Cannabis Cultivators Measure Their Success
LOS ANGELES — In cannabis cultivation, staying ahead of the curve requires not only the best products but also the best tools. Advanced Nutrients has taken a significant step in this direction with the development of BudLabs, an innovative mobile app designed to streamline the cultivation process and help growers achieve superior results. BudLabs: Your ...
Emerald Cup Unites with Local Oakland Dispensary Lounge Urbana for 20th Anniversary Celebrating Legacy and Community
OAKLAND — As the Emerald Cup marks its 20th anniversary this year, the event continues to evolve while staying true to its roots. Often hailed as the "Academy Awards of Cannabis," the Emerald Cup is celebrated for its commitment to honoring the best in cannabis while fostering a strong sense of community. Seeking a local ...
Advanced Nutrients Honored with International Cannabis Award for Best Fertilizer USA 2024
LOS ANGELES — Advanced Nutrients continues to lead the cannabis cultivation market, garnering the International Cannabis Award for Best Fertilizer USA 2024. This recognition underscores the company's longstanding commitment to innovation and excellence in cannabis cultivation. In a notable achievement coinciding with their presence at the International Cannabis Business Conference (ICBC) in Barcelona, Advanced Nutrients ...
Mary Jane Berlin 2024: Epicenter of European Cannabis Culture and Innovation
BERLIN—This week, Berlin is hosting one of the most anticipated events in the cannabis industry: Mary Jane Berlin. From June 14 to June 16, the sprawling Arena Berlin will transform into a vibrant hub for cannabis enthusiasts, industry professionals, and curious visitors alike. This annual event, now a staple in the European cannabis calendar, promises ...
High Tide Acquires Premium Cannabis Brand Queen of Bud
LOS ANGELES- In a strategic move High Tide Inc. has officially completed its acquisition of the esteemed Queen of Bud brand, including its intellectual property, trademarks, and other valuable assets. This acquisition, announced on March 15, 2024, marks a significant expansion of High Tide's impressive portfolio of consumer-facing brands, such as NuLeaf Naturals, FAB CBD, ...
Optimi Health Corp. Expands Its Global Reach with MDMA Supply Agreement to Israeli Research Institute
LOS ANGELES – In a landmark move for psychedelic medicine, Optimi Health Corp., a preeminent manufacturer of psychedelics licensed by Health Canada, has announced a groundbreaking international supply agreement with The Institute for Psychedelic Research at Tel Aviv University (IPR-TLV). This partnership marks Optimi's inaugural foray into the Israeli market, establishing a significant milestone in ...
Numinus Wellness Secures $6 Million in Public Offering to Fuel Psychedelic-Assisted Therapy Initiatives
LOS ANGELES- Numinus Wellness, a Vancouver-based healthcare company specializing in the innovative field of psychedelic-assisted therapies, has announced the successful completion of a significant financial milestone. Through a "bought deal" public offering, the company has raised $6 million, a move that positions it strongly within the burgeoning sector of mental health care. Financial Details and ...
FSD Pharma Announces Market Offering Agreement to Fund Research and Development
NEW YORK- FSD Pharma a biopharmaceutical company focused on developing a diverse portfolio of innovative assets and biotechnological solutions, has unveiled a strategic market offering agreement with H.C. Wainwright & Co. LLC. This collaborative effort paves the way for FSD Pharma to potentially offer and sell up to $11,154,232 in Class B subordinate voting shares ...
Clearmind Medicine Inc. Advances Psychedelic Therapeutics with New Patent Applications
NEW YORK– Clearmind Medicine Inc. a biotech firm dedicated to the discovery and development of novel psychedelic-derived therapeutics, has taken significant steps to enhance its intellectual property (IP) portfolio through the submission of three patent applications under the international Patent Cooperation Treaty (PCT). This strategic move, in collaboration with SciSparc Ltd. (Nasdaq: SPRC), a clinical-stage ...
MindBio Therapeutics Announces Completion of Groundbreaking Phase 2a LSD Microdose Trial
LOS ANGELES- In a significant advancement for psychiatric medicine, MindBio Therapeutics Corp., a pioneering biopharmaceutical company, has announced the successful completion of its Phase 2a clinical trial, marking a pivotal moment in the development of treatments for Major Depressive Disorder (MDD). This trial is notably the world's first to receive regulatory approval for the take-home ...
Silo Pharma Advances in Ketamine-Based Treatment for Chronic Pain
LOS ANGELES— In a significant stride toward innovative treatment for chronic pain conditions, Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company in its developmental stage, announced promising developments in its ketamine implant, SP-26. The company, known for its work on novel formulations and drug delivery systems for both traditional therapeutics and psychedelic treatments, is targeting ...
PharmaDrug Inc. Completes Private Placement to Bolster Corporate Initiatives
LOS ANGELES- a specialty pharmaceutical company, announce the successful completion of its previously disclosed non-brokered private placement, raising total gross proceeds of $326,000. In this offering, the company issued 6,520,000 units at a purchase price of $0.05 per unit, resulting in aggregate gross proceeds of up to $326,000. Each unit consists of one common share ...
